Email updates

Keep up to date with the latest news and content from BMC Palliative Care and BioMed Central.

Open Access Research article

An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide

Phillip J Newton1*, Patricia M Davidson1, Christine Sanderson2 and on behalf of the Improving Palliative Care through Clinical Trials (ImPaCCT) group

Author Affiliations

1 Centre for Cardiovascular & Chronic Care, Faculty of Nursing, Midwifery & Health, University of Technology Sydney, PO Box 123 Broadway, Sydney, NSW, 2007, Australia

2 Department of Palliative Care, Calvary Health Care, 91-111 Rocky Point Road, Beverley Park, Sydney, NSW, 2217, Australia

For all author emails, please log on.

BMC Palliative Care 2012, 11:6  doi:10.1186/1472-684X-11-6

Published: 30 April 2012

Additional files

Additional file 1:

The use of nebulised frusemide in Australian palliative care survey.

Format: PDF Size: 211KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data